Legend Biotech Corp Stock Price Prediction
| LEGN Stock | USD 17.85 0.42 2.30% |
Momentum 44
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.06) | EPS Estimate Current Year (1.41) | EPS Estimate Next Year 0.252 | Wall Street Target Price 66.3212 | EPS Estimate Current Quarter (0.12) |
Using Legend Biotech hype-based prediction, you can estimate the value of Legend Biotech Corp from the perspective of Legend Biotech response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Legend Biotech using Legend Biotech's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Legend using crowd psychology based on the activity and movement of Legend Biotech's stock price.
Legend Biotech Short Interest
An investor who is long Legend Biotech may also wish to track short interest. As short interest increases, investors should be becoming more worried about Legend Biotech and may potentially protect profits, hedge Legend Biotech with its derivative instruments, or be ready for some potential downside.
200 Day MA 31.8105 | Short Percent 0.1839 | Short Ratio 7.73 | Shares Short Prior Month 17.8 M | 50 Day MA 24.2747 |
Legend Biotech Corp Hype to Price Pattern
Investor biases related to Legend Biotech's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend Biotech Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Legend Biotech's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Legend Biotech.
Legend Biotech Implied Volatility | 0.95 |
Legend Biotech's implied volatility exposes the market's sentiment of Legend Biotech Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Legend Biotech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Legend Biotech stock will not fluctuate a lot when Legend Biotech's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Legend Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Legend because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Legend Biotech after-hype prediction price | USD 17.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Legend contract
Based on the Rule 16, the options market is currently suggesting that Legend Biotech Corp will have an average daily up or down price movement of about 0.0594% per day over the life of the 2026-03-20 option contract. With Legend Biotech trading at USD 17.85, that is roughly USD 0.0106 . If you think that the market is fully incorporating Legend Biotech's daily price movement you should consider acquiring Legend Biotech Corp options at the current volatility level of 0.95%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Legend Biotech Basic Forecasting Models to cross-verify your projections. Legend Biotech After-Hype Price Density Analysis
As far as predicting the price of Legend Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Legend Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Legend Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Legend Biotech Estimiated After-Hype Price Volatility
In the context of predicting Legend Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Legend Biotech's historical news coverage. Legend Biotech's after-hype downside and upside margins for the prediction period are 14.53 and 21.17, respectively. We have considered Legend Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Legend Biotech is not too volatile at this time. Analysis and calculation of next after-hype price of Legend Biotech Corp is based on 3 months time horizon.
Legend Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Legend Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Legend Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Legend Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.93 | 3.34 | 1.02 | 0.20 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
17.85 | 17.85 | 0.00 |
|
Legend Biotech Hype Timeline
Legend Biotech Corp is now traded for 17.85. The entity has historical hype elasticity of 1.02, and average elasticity to hype of competition of 0.2. Legend is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.93%. %. The volatility of related hype on Legend Biotech is about 1560.75%, with the expected price after the next announcement by competition of 18.05. About 48.0% of the company shares are owned by institutional investors. The book value of Legend Biotech was now reported as 5.48. The company recorded a loss per share of 1.28. Legend Biotech Corp had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Legend Biotech Basic Forecasting Models to cross-verify your projections.Legend Biotech Related Hype Analysis
Having access to credible news sources related to Legend Biotech's direct competition is more important than ever and may enhance your ability to predict Legend Biotech's future price movements. Getting to know how Legend Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Legend Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IRON | Disc Medicine | (0.57) | 9 per month | 0.00 | (0.04) | 4.42 | (4.35) | 16.19 | |
| ZLAB | Zai Lab | (0.21) | 9 per month | 0.00 | (0.31) | 4.56 | (4.21) | 10.32 | |
| AAPG | Ascentage Pharma Group | (2.39) | 9 per month | 0.00 | (0.14) | 5.25 | (6.36) | 16.72 | |
| TARS | Tarsus Pharmaceuticals | 3.81 | 10 per month | 0.00 | (0.06) | 3.78 | (3.76) | 10.59 | |
| ADPT | Adaptive Biotechnologies Corp | (0.12) | 13 per month | 3.84 | 0.03 | 9.94 | (4.95) | 29.55 | |
| SRRK | Scholar Rock Holding | 1.56 | 11 per month | 2.42 | 0.15 | 5.92 | (4.21) | 31.68 | |
| CELC | Celcuity LLC | 1.10 | 3 per month | 1.98 | 0.22 | 7.55 | (2.93) | 17.89 | |
| CGON | CG Oncology Common | (0.83) | 8 per month | 2.59 | 0.09 | 5.15 | (4.40) | 33.66 | |
| XENE | Xenon Pharmaceuticals | (0.42) | 9 per month | 1.94 | (0.01) | 3.78 | (2.71) | 10.56 | |
| IDYA | Ideaya Biosciences | 0.21 | 10 per month | 2.02 | 0.08 | 4.86 | (3.68) | 15.68 |
Legend Biotech Additional Predictive Modules
Most predictive techniques to examine Legend price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Legend using various technical indicators. When you analyze Legend charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Legend Biotech Predictive Indicators
The successful prediction of Legend Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Legend Biotech Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Legend Biotech based on analysis of Legend Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Legend Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Legend Biotech's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 3.98 | 4.07 | 3.66 | 3.85 | Revenue Per Share | 3.24 | 6.86 | 6.17 | 6.48 |
Pair Trading with Legend Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Legend Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with Legend Stock
| 0.61 | KAPA | Kairos Pharma | PairCorr |
| 0.64 | LEXX | Lexaria Bioscience Corp | PairCorr |
| 0.7 | LIXT | Lixte Biotechnology | PairCorr |
| 0.89 | PCSA | Processa Pharmaceuticals | PairCorr |
Moving against Legend Stock
| 0.85 | OABI | OmniAb Inc | PairCorr |
| 0.72 | CING | Cingulate | PairCorr |
| 0.72 | PPERY | Bank Mandiri Persero Earnings Call This Week | PairCorr |
| 0.6 | PEPG | PepGen | PairCorr |
| 0.32 | MOLN | Molecular Partners | PairCorr |
The ability to find closely correlated positions to Legend Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Legend Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Legend Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Legend Biotech Corp to buy it.
The correlation of Legend Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Legend Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Legend Biotech Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Legend Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Legend Biotech Basic Forecasting Models to cross-verify your projections. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Will Biotechnology sector continue expanding? Could Legend diversify its offerings? Factors like these will boost the valuation of Legend Biotech. Expected growth trajectory for Legend significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Legend Biotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.28) | Revenue Per Share | Quarterly Revenue Growth 0.7 | Return On Assets | Return On Equity |
Investors evaluate Legend Biotech Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Legend Biotech's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Legend Biotech's market price to deviate significantly from intrinsic value.
Understanding that Legend Biotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Legend Biotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Legend Biotech's market price signifies the transaction level at which participants voluntarily complete trades.